Myocardial and aortic stiffening in the early course of primary aldosteronism.
BACKGROUND
Primary aldosteronism (PA) has been experimentally and clinically linked to myocardial and vascular fibrosis, and it has been further associated with left ventricular (LV) structural adaptations.


OBJECTIVE
Functional cardiovascular adaptations in hypertensive patients with PA precede structural alterations in the early stages of the disease.


METHODS
We studied 17 hypertensive subjects with a recent diagnosis of PA (10 male patients, aged approximately 55 y, with office blood pressure [BP] of 137/88 mm Hg), and 30 essential hypertensives matched for age, sex, office BP levels, treatment status, and LV mass index (LVMI). Apart from standard 2-Dimensional (2-D) and conventional Doppler parameters, tissue Doppler imaging (TDI) methodology was used to assess LV diastolic function; averaging early and late diastolic mitral annular peak velocities (Emav/, Amav, Emav/Amav ratio) from 4 separate sites of measurement (septal, lateral, anterior, and inferior walls). Aortic stiffness was evaluated by means of carotid-femoral pulse wave velocity (cf-PWV) measurements.


RESULTS
Although transmitral E/A ratio was similar in both groups (0.95+/-0.26 versus 0.98+/-0.24, p=0.66), hypertensive subjects with PA compared with essential hypertensives are characterized by significantly higher relative wall thickness (0.50+/-0.07 versus 0.41+/-0.06, p<or=0.001), decreased values of Emav (7+/-1.7 versus 8.1+/-1.8 cm/s, p=0.048), and Emav/Amav ratio (0.63+/-0.16 versus 0.77+/-0.17, p=0.015). The higher PWV in the PA population failed to reach statistical significance (8.5+/-1.6 versus 7.9+/-0.9 msec, p=0.19).


CONCLUSIONS
Our study demonstrates altered LV geometry and TDI-revealed diastolic dysfunction in hypertensives with PA compared with demographically- and LVMI-matched essential hypertensives. Furthermore, the increased aortic stiffening in PA patients failed to reach statistical significance.
Tsioufis
Costas
C
Department of Cardiology, First Cardiology Clinic, University of Athens, Hippokration Hospital, Athens, Greece. ktsioufis@hippocratio.gr
Tsiachris
Dimitrios
D
Dimitriadis
Kyriakos
K
Stougiannos
Pavlos
P
Missovoulos
Platonas
P
Kakkavas
Apostolis
A
Stefanadis
Christodoulos
C
Kallikazaros
Ioannis
I
D001011:Aorta / Q000503:physiopathology*; D004452:Echocardiography; D004548:Elasticity; D005260:Female; D006321:Heart / Q000503:physiopathology*; D006801:Humans; D006929:Hyperaldosteronism / Q000150:complications / Q000000981:diagnostic imaging / Q000503:physiopathology*; D006973:Hypertension / Q000209:etiology / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D016277:Ventricular Function, Left; D020257:Ventricular Remodeling
J Am Soc Echocardiogr. 1989 Sep-Oct;2(5):358-67
2698218
Am J Cardiol. 1997 Apr 1;79(7):921-8
9104907
Am J Hypertens. 2006 Jan;19(1):13-8
16461184
Hypertension. 2002 Jul;40(1):23-7
12105133
N Engl J Med. 1998 Dec 17;339(25):1828-34
9854120
Curr Opin Cardiol. 2002 Jul;17(4):368-73
12151871
Am Heart J. 1996 May;131(5):982-7
8615320
J Am Coll Cardiol. 2005 Apr 19;45(8):1243-8
15837256
Eur Heart J. 2006 Nov;27(21):2588-605
17000623
Am J Hypertens. 2006 Jan;19(1):10-2
16461183
J Am Coll Cardiol. 2006 Dec 5;48(11):2293-300
17161262
Hypertension. 1996 May;27(5):1039-45
8621194
Am J Hypertens. 2006 Sep;19(9):909-14
16942932
Circulation. 1997 Mar 18;95(6):1471-8
9118515
Am J Hypertens. 2002 Oct;15(10 Pt 1):896-902
12372677
Heart. 2006 May;92(5):712-8
16614298
J Am Coll Cardiol. 2002 Jun 19;39(12):2005-11
12084601
J Hypertens. 2005 Sep;23(9):1745-50
16093921
J Clin Endocrinol Metab. 2005 Sep;90(9):5070-6
15941863
J Hypertens. 2006 May;24(5):965-72
16612260